Home
CoreRx, Inc.,

CoreRx, Inc., Market Share Analysis for November 2025

Preferred partner for drug delivery R&D, drug development, and manufacturing services. Located in Bend, Oregon.

Health > Biotechnology and Pharmaceuticals

Domaincorerxpharma.com

Year Founded2006

Employees201 - 500

Annual Revenue$25M - $50M

CoreRx, Inc.,

CoreRx, Inc., (including company regionals)

corerxpharma.com

See more website traffic and engagement information

CoreRx, Inc., Revenue up to November 2025 is 25M - 50M

revenue generated by CoreRx, Inc., top domains

CoreRx, Inc., top domains revenue over 3 years

Revenue for CoreRx, Inc., top domains

corerxpharma.com25M - 50M

See more with Sales Intelligence

Total visits to CoreRx, Inc.,'s top domains

Understand CoreRx, Inc., market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in CoreRx, Inc.,'s top domains

Analyze CoreRx, Inc., engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on CoreRx, Inc.,'s top domains

See how CoreRx, Inc., keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

CoreRx, Inc., top competitors by domain

Top similar sites in November 2025, ranked by their affinity

pharmatek.comCompany NamePharmatekEmployees51 - 200HQUnited States, California, San DiegoAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by CoreRx, Inc.,

These are the website technologies, by industry, used by CoreRx, Inc., top domains

Payment & Currencies (8)

Cart Functionality

Widget (7)

Twemoji

Advertising (4)

DoubleClick

Conversion & Analytics (3)

Google Analytics

More Technologies

11

See all

News & Signals from CoreRx, Inc.,

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCorerxpharma acquired Societal CDMO, Inc. for $0 on Apr 8th '24.CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) - CoreRx, Inc. ("CoreRx") today announced that it has completed its acquisition of Societal CDMO, Inc. ("Societal CDMO") (Nasdaq: SCTL), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.

NewsCorerxpharma hires David Vodak as Chief Scientific Officer.CoreRx and Bend Bioscience are happy to announce the appointment of Dr. David Vodak as its new Chief Scientific Officer (CSO).

NewsCorerxpharma launches 10th commercial partnered product.CoreRx launches 10th commercial partnered product.